Jeil Pharma Holdings Inc

KOSE:A002620 株式レポート

時価総額：₩136.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Jeil Pharma Holdings マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Seung-Soo Han

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権66.0%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

Mar 25
Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

Feb 27
These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jan 23
What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Dec 28
Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

Nov 23
Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

CEO（最高経営責任者

Seung-Soo Han (77 yo)

no data

在職期間

Seung Soo Han serves the Chairman of the Board and Chief Executive Officer of Jeil Pharma Holdings Inc (formerly known as Jeil Pharmaceutical Co., Ltd.)